Identification of Dyslipidemic Patients Attending Primary Care Clinics Using Electronic Medical Record (EMR) Data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) Database
- 209 Downloads
The objective of this study was to define the optimal algorithm to identify patients with dyslipidemia using electronic medical records (EMRs). EMRs of patients attending primary care clinics in St. John’s, Newfoundland and Labrador (NL), Canada during 2009–2010, were studied to determine the best algorithm for identification of dyslipidemia. Six algorithms containing three components, dyslipidemia ICD coding, lipid lowering medication use, and abnormal laboratory lipid levels, were tested against a gold standard, defined as the existence of any of the three criteria. Linear discriminate analysis, and bootstrapping were performed following sensitivity/specificity testing and receiver’s operating curve analysis. Two validating datasets, NL records of 2011–2014, and Canada-wide records of 2010–2012, were used to replicate the results. Relative to the gold standard, combining laboratory data together with lipid lowering medication consumption yielded the highest sensitivity (99.6%), NPV (98.1%), Kappa agreement (0.98), and area under the curve (AUC, 0.998). The linear discriminant analysis for this combination resulted in an error rate of 0.15 and an Eigenvalue of 1.99, and the bootstrapping led to AUC: 0.998, 95% confidence interval: 0.997–0.999, Kappa: 0.99. This algorithm in the first validating dataset yielded a sensitivity of 97%, Negative Predictive Value (NPV) = 83%, Kappa = 0.88, and AUC = 0.98. These figures for the second validating data set were 98%, 93%, 0.95, and 0.99, respectively. Combining laboratory data with lipid lowering medication consumption within the EMR is the best algorithm for detecting dyslipidemia. These results can generate standardized information systems for dyslipidemia and other chronic disease investigations using EMRs.
KeywordsElectronic medical records Algorithm Dyslipidemia Data mining
We thank Ms. Kathleen Murphy for language editing of the manuscript.
Study Design: SA, EAE, JO; Data collection: SA, EAE; Manuscript writing: SA, JO, EAE; Critical comments on the manuscript: EAE, PD, KAB, MG, PD, MM.
Compliance with Ethical Standards
The authors have no potential conflicts to declare.
This study was funded by the Newfoundland and Labrador Centre for Applied Health Research (NLCAHR). All of the study steps including data analysis, interpreting the results, and manuscript writing were performed with the support of the mentioned funding source.
- 1.Public health agency of Canada, Canadian institute for health information, Heart and stroke foundation of Canada, Statistics Canada, Tracking heart disease and stroke in Canada, 2009. Available from: http://www.phac-aspc.gc.ca/publicat/2009/cvd-avc/pdf/cvd-avs-2009-eng.pdf.
- 4.Asghari, S., Aref-Eshghi, E., Hurley, O., Godwin, M., Duke, P., Williamson, T., et al., Does the prevalence of dyslipidemias differ between Newfoundland and the rest of Canada? Findings from the electronic medical Records of the Canadian Primary Care Sentinel Surveillance Network. Front Cardiovasc Med. 2:1, 2015.CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Crawford, A.G., Cote, C., Couto, J., Daskiran, M., Gunnarsson, C., Haas, K., et al., Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: findings from the GE centricity electronic medical record database. Popul Health Manag. 13(3):151–161, 2010.CrossRefPubMedGoogle Scholar
- 16.McAdam-Marx, C., Ye, X., Sung, J.C., Brixner, D.I., and Kahler, K.H., Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting. Clin Ther. 31(5):1116–1123, 2009.CrossRefPubMedGoogle Scholar
- 17.Biskupiak, J.E., Kim, J., Phatak, H., and Wu, D., Prevalence of high-risk cardiovascular conditions and the status of hypertension management among hypertensive adults 65 years and older in the United States: analysis of a primary care electronic medical records database. J Clin Hypertens (Greenwich). 12(12):935–944, 2010.CrossRefGoogle Scholar
- 19.Nishida, Y., Takahashi, Y., Nakayama, T., Soma, M., Kitamura, N., and Asai, S., Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records. Cardiovasc Diabetol. 9:38, 2010.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Pettersson, B., Ambegaonkar, B., Sazonov, V., Martinell, M., Stalhammar, J., and Wandell, P., Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among swedish patients with dyslipidemia (PRIMULA). BMC Public Health. 10:737, 2010.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Zhang, Q., Rajagopalan, S., Mavros, P., Engel, S.S., Davies, M.J., Yin, D., et al., Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database. Advances in Therapy. 27(4):223–232, 2010.CrossRefPubMedGoogle Scholar
- 31.Asghari, S., Aref-Eshghi, E., Godwin, M., Duke, P., Williamson, T., and Mahdavian, M., Single and mixed dyslipidemia in Canadian primary care population: a comparison of statin-treated and untreated subjects from electronic medical records. BMJ open. 5:e007954, 2015.CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Aref-Eshghi, E., Leung, J., Godwin, M., Duke, P., Williamson, T., Mahdavian, M., and Asghari, S., Low density lipoprotein cholesterol control in Canadian high risk cardiovascular population: findings from Canadian primary care sentinel surveillance network database. Lipids Health Dis. 14:60, 2015.CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Hodge, T., EMR, EHR, and PHR – why all the confusion? Canada health infoway, 2011. Available from https://www.infoway-inforoute.ca/en/what-we-do/blog/digital-health-records/6852-emr-ehr-and-phr-why-all-the-confusion. Last accessed 24 Jan 2017.
- 34.Genest, J., McPherson, R., Frohlich, J., Anderson, T., Campbell, N., Carpentier, A., et al., Canadian cardiovascular society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 25(10):567–579, 2009.CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Oake, J., Aref-Eshghi, E., Godwin, M., Collins, K., Aubrey-Bassler, K., Duke, P., Mahdavian, M., and Asghari, S., Using electronic medical record to identify patients with dyslipidemia in primary care settings: international classification of disease code matters from one region to a national database. Biomed Inform Insights. 9(1):1–7, 2017.Google Scholar